Unit of Functional Neurosurgery, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK.
Eur J Neurosci. 2010 Oct;32(7):1128-34. doi: 10.1111/j.1460-9568.2010.07415.x.
Gilles de la Tourette Syndrome (GTS) is characterized by multiple motor and one or more vocal/phonic tics. Psychopathology and co-morbidity occur in approximately 80-90% of clinical cohorts. The most common psychopathologies are attention deficit hyperactivity disorder, obsessive-compulsive behaviours, obsessive-compulsive disorder, depression, anxiety and certain behavioural disorders. In severe GTS patients who are refractory to medication and other therapies, deep brain stimulation (DBS) is investigated. To date there have been some 50-55 patients who have received DBS in 19 centres worldwide. Nine different brain targets in the thalamus, the pallidum, and the ventral caudate and anterior internal capsule have been stimulated. This paper reviews critically and in detail all studies published to date. Only two studies on just a few patients fulfil some of the evidence-based criteria. DBS for GTS is therefore still highly experimental.
妥瑞氏症候群(Gilles de la Tourette Syndrome,GTS)的特征是多种运动性抽搐和一种或多种发声性抽搐。大约 80-90%的临床病例会出现精神病理学和共病。最常见的精神病理学是注意力缺陷多动障碍、强迫症行为、强迫症、抑郁、焦虑和某些行为障碍。对于药物治疗和其他治疗无效的严重 GTS 患者,会考虑进行深部脑刺激(DBS)。迄今为止,全球已有 19 个中心的约 50-55 名患者接受了 DBS 治疗。已经刺激了丘脑、苍白球、腹侧尾状核和前内囊的 9 个不同的脑目标。本文批判性地详细回顾了迄今为止发表的所有研究。只有两项关于少数患者的研究符合部分循证标准。因此,DBS 治疗 GTS 仍然是高度实验性的。